Summary
GlobalData's clinical trial report, “Tick Borne Encephalitis Global Clinical Trials Review, H2, 2016" provides an overview of Tick Borne Encephalitis clinical trials scenario. This report provides top line data relating to the clinical trials on Tick Borne Encephalitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
Pfizer Inc.
Baxter International Inc.
Microgen Scientific Industrial Company for Immunobiological Medicines
Novartis AG
SGS North America, Inc.
Monipol sp. z o.o.
BIOVOMED
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Five Countries Contributing to Clinical Trials in Europe 8
Top Countries Contributing to Clinical Trials in North America 9
Clinical Trials by G7 Countries: Proportion of Tick Borne Encephalitis to Central Nervous System Clinical Trials 10
Clinical Trials by Phase in G7 Countries 11
Clinical Trials in G7 Countries by Trial Status 12
Clinical Trials by E7 Countries: Proportion of Tick Borne Encephalitis to Central Nervous System Clinical Trials 13
Clinical Trials by Phase 14
In Progress Trials by Phase 15
Clinical Trials by Trial Status 16
Clinical Trials by End Point Status 17
Subjects Recruited Over a Period of Time 18
Clinical Trials by Sponsor Type 19
Prominent Sponsors 20
Top Companies Participating in Tick Borne Encephalitis Therapeutics Clinical Trials 21
Prominent Drugs 22
Clinical Trial Profile Snapshots 23
Appendix 47
Abbreviations 47
Definitions 47
Research Methodology 48
Secondary Research 48
About GlobalData 49
Contact Us 49
Disclaimer 49
Source 50
List of Tables
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials by Region, 2016* 5
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Tick Borne Encephalitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 8
Tick Borne Encephalitis Therapeutics Clinical Trials, North America, Top Countries, 2016* 9
Proportion of Tick Borne Encephalitis to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 10
Tick Borne Encephalitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 11
Tick Borne Encephalitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 12
Proportion of Tick Borne Encephalitis to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 13
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials by Phase, 2016* 14
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 15
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 16
Tick Borne Encephalitis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 17
Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 18
Tick Borne Encephalitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 19
Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 20
Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 21
Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 22
List of Figures
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Tick Borne Encephalitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 8
Proportion of Tick Borne Encephalitis to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 10
Tick Borne Encephalitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 11
Tick Borne Encephalitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 12
Proportion of Tick Borne Encephalitis to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 13
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 14
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 15
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 16
Tick Borne Encephalitis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 17
Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 18
Tick Borne Encephalitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 19
Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 20
Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 21
Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 22
GlobalData Methodology 48
